Cargando…

Bortezomib: A New Promising Therapy for Early Antibody-Mediated Rejection After Liver Transplantation?

Detalles Bibliográficos
Autores principales:	Chedid, Marcio F., Rodrigo, Emilio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Commentary—Invited
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791596/ https://www.ncbi.nlm.nih.gov/pubmed/31723587 http://dx.doi.org/10.1097/TXD.0000000000000931

Ejemplares similares

The Effect of Bortezomib on Antibody-Mediated Rejection after Kidney Transplantation
por: Lee, Juhan, et al.
Publicado: (2015)

Bortezomib alleviates antibody‐mediated rejection in kidney transplantation by facilitating Atg5 expression
por: Cheng, Hong, et al.
Publicado: (2021)

Rituximab use in late antibody-mediated rejection
por: Bansal, S. B.
Publicado: (2016)

Bortezomib Against Refractory Antibody-Mediated Rejection After ABO-Incompatible Living-Donor Liver Transplantation: Dramatic Effect in Acute-Phase?
por: Tajima, Tetsuya, et al.
Publicado: (2019)

Selection criteria in liver transplantation for hepatocellular carcinoma: an ongoing evolution
por: Line, Pål-Dag
Publicado: (2022)

Stem cells, gene therapy, and advanced medical management hold promise in the treatment of male infertility
por: Smith, Ryan P, et al.
Publicado: (2016)

Bortezomib-Containing Multimodality Treatment for Antibody-Mediated Rejection with Anti-HLA and Anti-AT1R Antibodies after Kidney Transplantation
por: Iesari, Samuele, et al.
Publicado: (2017)

The New Challenge in Pediatric Liver Transplantation: Chronic Antibody-Mediated Rejection
por: Uebayashi, Elena Yukie, et al.
Publicado: (2022)

Bortezomib in late antibody-mediated kidney transplant rejection (BORTEJECT Study): study protocol for a randomized controlled trial
por: Eskandary, Farsad, et al.
Publicado: (2014)

Genetics and genomics in Brazil: a promising future
por: Passos-Bueno, Maria Rita, et al.
Publicado: (2014)

Regulatory B cells: TIM‐1, transplant tolerance, and rejection
por: Cherukuri, Aravind, et al.
Publicado: (2021)

Invited Commentary: Overall Survival in Patients with Stage IV Pan-NET Eligible for Liver Transplantation
por: Borel Rinkes, Inne H. M.
Publicado: (2022)

Emerging Therapies for Antibody-Mediated Rejection in Kidney Transplantation
por: Abuazzam, Farah, et al.
Publicado: (2023)

It’s good to be young: Early survival data for Covid-19 lung transplant recipients
por: Kulshrestha, Kevin, et al.
Publicado: (2022)

Death after lung transplantation: improving long term survival despite perilous early postoperative years
por: Erasmus, Michiel E., et al.
Publicado: (2020)

Fibroblast Growth Factor-2: A Promising Biomarker for Anxiety and Trauma Disorders
por: Graham, Bronwyn M
Publicado: (2017)

The Preliminary Results of Bortezomib Used as A Primary Treatment for An Early Acute Antibody-Mediated Rejection after Kidney Transplantation—A Single-Center Case Series
por: Kolonko, Aureliusz, et al.
Publicado: (2020)

Neurostimulation as a promising epilepsy therapy
por: Lin, Yicong, et al.
Publicado: (2017)

Rituximab in Combination With Bortezomib, Plasmapheresis, and High-Dose IVIG to Treat Antibody-Mediated Renal Allograft Rejection
por: Waiser, Johannes, et al.
Publicado: (2016)

Updates on antibody-mediated rejection in intestinal transplantation
por: Wu, Guo-Sheng
Publicado: (2016)

Antibody-mediated rejection after lung transplantation
por: Bery, Amit I., et al.
Publicado: (2020)

Anti-complement 5 antibody ameliorates antibody-mediated rejection after liver transplantation in rats
por: Tajima, Tetsuya, et al.
Publicado: (2023)

Non-invasive screening for sub-clinical antibody-mediated rejection as a new tool for indication of kidney allograft biopsy
por: Kozakowski, Nicolas
Publicado: (2019)

Imagining a Better Outcome for Chronic Antibody-Mediated Rejection—Will Blocking Interleukin-6 Signaling Help?
por: Muthukumar, Thangamani, et al.
Publicado: (2022)

Acute Antibody-mediated Rejection Coexisting With T Cell–mediated Rejection in Pediatric ABO-incompatible Transplantation
por: Yanagi, Yusuke, et al.
Publicado: (2022)

Belatacept Treatment of Recurrent Late-onset T Cell–mediated Rejection/Antibody-mediated Rejection With De Novo Donor-specific Antibodies in a Liver Transplant Patient
por: Klintmalm, Göran B., et al.
Publicado: (2022)

Brief Report on the 11th Meeting of the European Forum on Antiphospholipid Antibodies
por: Chayouâ, Walid, et al.
Publicado: (2019)

Liver, Heart, Death… Can This Sequence Be Broken?
por: Manka, Paul
Publicado: (2023)

Antibody-Mediated Rejection in Kidney Transplantation: A Review
por: Puttarajappa, Chethan, et al.
Publicado: (2012)

Antibody-Mediated Rejection: An Evolving Entity in Heart Transplantation
por: Chih, Sharon, et al.
Publicado: (2012)

Acute antibody-mediated rejection after intestinal transplantation
por: Wu, Guo-Sheng, et al.
Publicado: (2016)

Postoperative pancreatic fistula: focus should be shifted from early drain removal to early management
por: van Santvoort, Hjalmar C
Publicado: (2023)

Isolated native renal hydatidosis in a renal transplant patient: The case for an aggressive approach
por: Mubarak, Muhammed
Publicado: (2018)

Through thick and thin: Risk of venous thromboembolism vs bleeding after abdominal transplant
por: Whitrock, Jenna N., et al.
Publicado: (2023)

The conclusion of reducing acute rejection after liver transplantation by machine perfusion should be extrapolated with caution
por: Liang, Aijun, et al.
Publicado: (2023)

Do maternal anti–N‐methyl‐D‐aspartate receptor antibodies promote development of neuropsychiatric disease in children?
por: Pröbstel, Anne‐Katrin, et al.
Publicado: (2019)

The ILAE at 110—Reflections on the last decade
por: Wiebe, Samuel, et al.
Publicado: (2019)

Commentary on: “Human umbilical cord wharton's jelly-derived mesenchymal stem cell transplantation could improve diabetic intracavernosal pressure”
por: Dimitriadis, Fotios, et al.
Publicado: (2021)

Tackling Chronic Kidney Transplant Rejection: Challenges and Promises
por: Lai, Xingqiang, et al.
Publicado: (2021)

The Most Promising Biomarkers of Allogeneic Kidney Transplant Rejection
por: Rogulska, Karolina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gkd6ppak7tovlj6qn8et708d9g